We are pleased to announce the winners of the 2021 BGI Genomics ANZ Grant. Congratulations to the winners!
Drumroll... MGI announces 2021 DNBSEQ™ MPS Research Grant winners: Dr. Christian Nefzger, University of Queensland, Dr. Darren Korbie, University of Queensland, A. Prof. Michael Hildebrand, University of Melbourne, Dr. Hii Kieng Soon, University of Malaya, and Dr. Colm Carraher, Plant&Food Research. Congratulations!
MGI, a world-leading life science technology innovator, announces the opening of MGI Australia Demonstration Laboratory (Demo Lab) to support the users in Asia-Pacific (APAC). The lab is dedicated to offering the researchers and users in unique access to MGI's cutting-edge technology portfolio including DNBSEQ™ platforms*, laboratory automation systems and bioinformatics products, for application development, technology assessment and technical support. MGI Australia will announce a $100,000-worth grant program to APAC scientists in August.
BGI Australia is proud to be the supplier for Pathology Queensland’s testing equipment and kits, contributing to safeguarding the people living in Queensland. BGI’s proprietary COVID-19 Testing Solution installed in the Pathology Queensland Infectious Diseases Lab (IDL) in Herston Health Precinct has officially started operation in April by running samples that are collected from across the river city. The “BGI system”, dubbed by the lab staff, surpassed the 10,000-test milestone in less than a month. The integrated system is expected to handle 4,700 tests daily at the maximum capacity, with a 24-hour turnaround time from swab collection at a clinic or hospital, to reported result.
Dr. Ian Mackay, the IDL’s Senior Molecular Scientist said, “our approach is to establish a diverse portfolio of advanced technologies to best serve Queenslanders. We appreciate how quickly the BGI team respond to our ongoing technical needs and how efficiently the equipment and testing kits were supplied. We are handling approximately 1,100 tests per day as there is no community transmission in the Brisbane region, but the number we process continues to grow and we are well placed to respond should any new clusters occur in Brisbane’s future.”
With a local team of technical specialists and engineers, BGI Australia offers strong support to the customers across Australia. Dr. Bicheng Yang, Director of BGI Australia, said “This project is very special for us as Brisbane is our home city, where most of the team members are based, and we are located in the same building as IDL. This certainly will benefit response time and service to ensure that everything runs smoothly and sustains the highest quality to deliver reliable results for the tests.”
The Pathology Queensland Infectious Diseases Laboratory is a high-throughput molecular laboratory operating in Herston, with surge capacity to assist other Pathology Queensland laboratories across Queensland. Pathology Queensland, part of Queensland Health, provides diagnostic pathology services to all Hospital and Health Services across metro, regional and remote Queensland.
Please read the full media release below.
BGI’s remarkable journey fighting COVID-19, from BGI’s emergency response since the very beginning of the outbreak to BGI’s battle-proven COVID-19 solutions to provide timely detection and intervention support.
Check in on the latest news at BGI Australia.
Keep an eye out here for our promotions and grants. Be notified when applications open.
Join us at upcoming tradeshows, conferences and other events. We are in the process of confirming our plans for 2022. Visit us back soon.
Register to attend/view our upcoming and past free Webinars, brought to you by BGI Genomics & MGI.
Since the completion of Human Genome Project, BGI has evolved into a genomics giant with a global footprint. Its core capabilities cover research, sequencing services, advanced tools for life sciences, and reading, writing, and storage of genetic resources,
BGI is committed to multi-disciplinary research in life sciences, biotechnology and healthcare applications. Today, BGI actively participates in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a network of collaborators.
Check out our latest range of MGI sequencing platforms and diagnostic devices.
We provide a wide array of integrated genomic sequencing services and proteomic services across a broad range of applications in basic research, clinical research, genetic testing and screening, drug discovery and development, agriculture and biodiversity preservation and sustainability.
We believe that partnerships are critical to help foster innovation and growth. We partner with diverse players from research and industry organizations who share our vision. We have formed strong alliances within the genomics community and beyond, and continuously seek collaborative opportunities.
We are committed to our customers’ success, and aim for excellence as we work together to find new ways to engage, support customers and identify exciting development opportunities.
L6, CBCRC Building, 300 Herston Road, Herston, Queensland 4006, Australia
Monday — Friday: 9AM — 5PM
Saturday — Sunday: Closed